Author

Matheen Muhammadh Milhan

Institute of Biochemistry, Molecular Biology and Biotechnology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Kanishka Sithira SenathilakeiD· 2 shared Sameera R. SamarakooniD· 2 shared Sandani De Vass Gunawardane· 2 shared Anusha Kanagasundaram· 1 shared Chamudi PereraiD· 1 shared Dipun Nirmal Perera· 1 shared Duvinika Chalani Senavirathna· 1 shared Duvinika Chalani Senevirathne· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Kanishka Sithira SenathilakeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsPLoS ONEPeer-reviewedJul 1, 2026

A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer

Sandani De Vass Gunawardane, Matheen Muhammadh Milhan, Poorni Chanuka Rathnayaka…·Sameera R. Samarakoon

This study uses network pharmacology and molecular docking to explore Vernolac's anticancer mechanisms, identifying key phytochemicals and pathways involved in apoptosis, immune modulation, and chemoradiosensitization.

2 citations

statistical modelmachine learning (classical)

𝕏 PostBluesky

Pharmacology & ToxicologyEgyptian Journal of Basic and Applied SciencesPeer-reviewedDec 2, 2025

In vitro anti-cancer properties of a commercially available polyherbal nutraceutical (Vernolac) capsule on cancer stem cell-like (NTERA-2 cl.D1) cells.

Poorni Chanuka Rathnayake, Duvinika Chalani Senavirathna, Matheen Muhammadh Milhan…·Sameera R. Samarakoon

This study evaluates the anti-cancer effects of Vernolac extract on NTERA-2 cl.D1 cancer stem-like cells, showing significant cytotoxicity and apoptosis induction with minimal impact on non-cancerous cells.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky